NVO Bullish Swing Incoming! Call Strike $55 🚀 NVO Swing Alert – 2025-08-15 🚀
**Sentiment:** Moderate Bullish
**Setup:** Call Option Trade
---
## 📈 Market Snapshot
* **Daily RSI:** 44.7 → Neutral but trending upward
* **5 & 10-Day Trend:** +2.94% / +9.11% → Short-term bullish momentum
* **Volume:** Avg (1.0x) → Weak breakout confirmation
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
73.75 MXN
291.41 B MXN
837.97 B MXN
3.16 B
About NOVO NORDISK B A/S
Sector
Industry
CEO
Maziar Mike Doustdar
Website
Headquarters
Bagsværd
Founded
1923
ISIN
DK0062498333
FIGI
BBG01292CB20
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Related stocks
Once in a Lifetime Opportunity and the Psychology behind itOnce in a Lifetime Opportunity and the Psychology behind it
There are moments in the market that happen so rarely , they feel almost mythical when they finally arrive. Novo Nordisk NYSE:NVO has just given us one of those moments.
If you’ve been following my work, you might remember my previo
$NVO Elliott Wave Count – Eyeing $113 Before Big C-Wave DropPrimary Elliott Wave Scenario – NYSE:NVO
I believe NYSE:NVO completed a multi-year Wave I in May 2024. Since then, we’ve seen the A-wave of a larger ABC correction play out.
The price dipped below the 0.618 Fib at $56.63, but reclaimed key support at $47.75. My current primary count suggests th
60$ coming monthsGrabbed late sept 60C further out would be safer. Trading at an EV/EBIT multiple of 9.8x, NVO is at its lowest valuation in over a decade, suggesting a potential bargain for a company with strong fundamentals and steady growth. Analysts project 21.35% EPS growth next year (from $3.84 to $4.66), supp
Fib resistance + RSI bullish reversal After the bearish news earlier today, it seems like Novo has had its final capitulation.
There's a fib resistance + historical resistance dating back to '21-'22.
On the weekly, the RSI is also presenting a bullish divergence - although we may want to await the closing of this week to confirm this.
T
NVO Bulls Load $60 Calls for 100%+ Weekly Gains!
# 🚀 NVO Weekly Options Trade Setup (08/24/2025)
**Consensus:** 🔥 Strong Bullish — All 5 AI models favor weekly calls!
**Market Context:** Low VIX (\~14.2) ✅, Heavy Call Flow (C/P 3.43) 📈, Institutional Volume ↑ 1.3x
---
lish on weekly horizon
* **Strategy:** Single‑leg weekly CALLs
* **Expiry:*
$NOV: Lot of loss in weight loss. Is it in buy zone? Currently the weight loss drugs are having a severe loss of weightage in the corresponding indices. The poster child of weight loss and diabetes drugs XETR:NOV and NYSE:LLY are seeing some of the worst drawdown in their history. Today we look at the worst of the 2 in this space which is $NOV. N
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where NOVOB/N is featured.
Frequently Asked Questions
The current price of NOVOB/N is 1,069.98 MXN — it has decreased by −1.48% in the past 24 hours. Watch NOVO NORDISK A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange NOVO NORDISK A/S stocks are traded under the ticker NOVOB/N.
NOVOB/N stock has risen by 9.74% compared to the previous week, the month change is a −16.56% fall, over the last year NOVO NORDISK A/S has showed a −57.61% decrease.
We've gathered analysts' opinions on NOVO NORDISK A/S future price: according to them, NOVOB/N price has a max estimate of 1,818.37 MXN and a min estimate of 872.82 MXN. Watch NOVOB/N chart and read a more detailed NOVO NORDISK A/S stock forecast: see what analysts think of NOVO NORDISK A/S and suggest that you do with its stocks.
NOVOB/N reached its all-time high on Jun 14, 2024 with the price of 2,708.33 MXN, and its all-time low was 866.25 MXN and was reached on Aug 7, 2025. View more price dynamics on NOVOB/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NOVOB/N stock is 1.50% volatile and has beta coefficient of 1.52. Track NOVO NORDISK A/S stock price on the chart and check out the list of the most volatile stocks — is NOVO NORDISK A/S there?
Today NOVO NORDISK A/S has the market capitalization of 4.70 T, it has increased by 9.30% over the last week.
Yes, you can track NOVO NORDISK A/S financials in yearly and quarterly reports right on TradingView.
NOVO NORDISK A/S is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
NOVOB/N earnings for the last quarter are 17.61 MXN per share, whereas the estimation was 17.53 MXN resulting in a 0.46% surprise. The estimated earnings for the next quarter are 17.59 MXN per share. See more details about NOVO NORDISK A/S earnings.
NOVO NORDISK A/S revenue for the last quarter amounts to 227.11 B MXN, despite the estimated figure of 227.39 B MXN. In the next quarter, revenue is expected to reach 224.94 B MXN.
NOVOB/N net income for the last quarter is 78.32 B MXN, while the quarter before that showed 86.19 B MXN of net income which accounts for −9.13% change. Track more NOVO NORDISK A/S financial stats to get the full picture.
NOVO NORDISK A/S dividend yield was 1.83% in 2024, and payout ratio reached 50.28%. The year before the numbers were 1.35% and 50.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 24, 2025, the company has 76.3 K employees. See our rating of the largest employees — is NOVO NORDISK A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVO NORDISK A/S EBITDA is 475.05 B MXN, and current EBITDA margin is 50.95%. See more stats in NOVO NORDISK A/S financial statements.
Like other stocks, NOVOB/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVO NORDISK A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVO NORDISK A/S technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVO NORDISK A/S stock shows the sell signal. See more of NOVO NORDISK A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.